These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36300967)

  • 1. Capping Prescription Drug Costs: State Initiatives to the Rescue?
    Adashi EY; Cohen IG
    R I Med J (2013); 2022 Nov; 105(9):53-50. PubMed ID: 36300967
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicaid prescription limits: policy trends and comparative impact on utilization.
    Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA
    BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing Prescription Drug Costs in the United States.
    Arbiser JL
    JAMA; 2016 Dec; 316(22):2430-2431. PubMed ID: 27959990
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors Influencing Prescription Drug Costs in the United States.
    Roy V; Hawksbee L; King L
    JAMA; 2016 Dec; 316(22):2431. PubMed ID: 27959991
    [No Abstract]   [Full Text] [Related]  

  • 5. Factors Influencing Prescription Drug Costs in the United States-Reply.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2016 Dec; 316(22):2431-2432. PubMed ID: 27959994
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between Medicaid Prescription Drug Limits and Access to Medications and Health Care Use Among Young Adults With Disabilities.
    Geiger CK; Cohen JL; Sommers BD
    JAMA Health Forum; 2021 Jun; 2(6):e211048. PubMed ID: 35977173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State Medicaid pharmacy payments and their relation to estimated costs.
    Adams EK; Kreling DH; Gondek K
    Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Prescription Drug Coverage on Mortality: Evidence from Medicaid Implementation.
    Clayton DH
    J Health Econ; 2019 Jan; 63():100-113. PubMed ID: 30530251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soaring Prescription Drug Prices.
    Cohen SS
    Policy Polit Nurs Pract; 2016 Aug; 17(3):115-117. PubMed ID: 27895240
    [No Abstract]   [Full Text] [Related]  

  • 11. Value-Based Pricing and State Reform of Prescription Drug Costs.
    Hwang TJ; Kesselheim AS; Sarpatwari A
    JAMA; 2017 Aug; 318(7):609-610. PubMed ID: 28692713
    [No Abstract]   [Full Text] [Related]  

  • 12. The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults:Evidence from Recent Medicaid Expansions.
    Ghosh A; Simon K; Sommers BD
    J Health Econ; 2019 Jan; 63():64-80. PubMed ID: 30458314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State initiatives on prescription drugs: creating a more functional market.
    Reforming States Group
    Health Aff (Millwood); 2003; 22(4):128-36. PubMed ID: 12889760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State strategies to address medicaid prescription spending: negotiated pricing vs price transparency.
    Noh S; Janousek CL; Park JH
    Health Econ Policy Law; 2021 Apr; 16(2):201-215. PubMed ID: 32349843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018.
    Yeung K; Dusetzina SB; Basu A
    JAMA Netw Open; 2021 Jun; 4(6):e2113393. PubMed ID: 34125219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Average wholesale price for prescription drugs: is there a more appropriate pricing mechanism?
    Gencarelli DM
    NHPF Issue Brief; 2002 Jun; (775):1-19. PubMed ID: 12083159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures.
    Martin BC; McMillan JA
    Med Care; 1996 Jul; 34(7):686-701. PubMed ID: 8676607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number Of Medicaid Prescriptions Grew, Drug Spending Was Steady In Medicaid Expansion States.
    Wen H; Borders TF; Druss BG
    Health Aff (Millwood); 2016 Sep; 35(9):1604-7. PubMed ID: 27605639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription drug costs for dually eligible people in a medicaid home- and community-based services program.
    Phillips VL; Atherly A
    J Am Geriatr Soc; 2002 Jul; 50(7):1283-8. PubMed ID: 12133026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One pill, many prices: variation in prescription drug prices in selected government programs.
    Gencarelli DM
    Issue Brief George Wash Univ Natl Health Policy Forum; 2005 Aug; (807):1-20. PubMed ID: 16167399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.